BioXcel Therapeutics (BTAI) Short term Debt (2018 - 2026)
BioXcel Therapeutics (BTAI) posted quarterly Short term Debt of $22.4 million for Q1 2026, up 299.98% year-over-year from $5.6 million in Q1 2025, and down 10.03% quarter-over-quarter from $24.9 million in Q4 2025.
BioXcel Therapeutics (BTAI) Short term Debt (2018 - 2026) Analysis & Trends
BioXcel Therapeutics' Short term Debt history runs 8 years deep, the most recent figure standing at $22.4 million for Q1 2026.
- In Q1 2026, Short term Debt rose 299.98% year-over-year to $22.4 million; the TTM figure through Mar 2026 stood at $22.4 million (up 299.98% YoY), while the FY2025 annual figure was $24.9 million, changed N/A from the prior year.
- Short term Debt for Q1 2026 stood at $22.4 million, down from $24.9 million in the prior quarter.
- The five-year high for Short term Debt was $24.9 million in Q4 2025, with the low at $56000.0 in Q1 2022.
- The 4-year median for Short term Debt is $792000.0 (2023), against an average of $7.0 million.
- The sharpest annual moves came in 2022 and 2023: Short term Debt jumped 74.68% in 2022, then jumped 578.57% in 2023.
- BioXcel Therapeutics' Short term Debt stood at $422000.0 in 2022, then surged by 72.99% to $730000.0 in 2023, then surged by 3315.21% to $24.9 million in 2025, then retreated by 10.03% to $22.4 million in 2026.
- Business Quant data shows BTAI's Short term Debt at $22.4 million in Q1 2026, $24.9 million in Q4 2025, and $16.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | BioXcel Therapeutics | 24.29 Mn | 24.29 Mn | 160,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 104.45 Mn |
| Mar 31, 2026 | 22.43 Mn |
| Dec 31, 2025 | 24.93 Mn |
| Sep 30, 2025 | 16.82 Mn |
| Jun 30, 2025 | 11.22 Mn |
| Mar 31, 2025 | 5.61 Mn |
| Sep 30, 2023 | 730,000.00 |
| Jun 30, 2023 | 854,000.00 |
| Mar 31, 2023 | 380,000.00 |
| Dec 31, 2022 | 422,000.00 |
| Sep 30, 2022 | 269,000.00 |
| Jun 30, 2022 | 296,000.00 |
| Mar 31, 2022 | 56,000.00 |
| Dec 31, 2021 | 204,000.00 |
| Sep 30, 2021 | 154,000.00 |
| Jun 30, 2021 | 106,000.00 |
| Dec 31, 2020 | 157,000.00 |
| Sep 30, 2020 | 208,000.00 |
| Dec 31, 2019 | 64,000.00 |
| Mar 31, 2018 | 13,000.00 |